Media & Resources

Blog perspective from a graduate of the first cohort of the IAVI ADVANCE Leadership Development Program.

Sustaining momentum in research, development, and innovation for HIV prevention and other disease areas in the context of shrinking global resources.

First shipment of IAVI’s Sudan virus (SUDV) vaccine candidate has arrived in Entebbe, Uganda.

In the wake of cutting-edge science, it is essential to nurture a community-rooted and participant-centered approach to accelerate vaccine research.

Jama Dalel, Ph.D., post-doctoral researcher, IAVI–Human Immunology Laboratory (HIL), Imperial College, London

Jyoti Sutar, Ph.D., senior research associate, Antibody Translational Research Program (previously the HIV Vaccine Translational Research Laboratory)

We must plan for their introduction and demand what is needed for new TB vaccines to reach End TB targets, experts say.

Jayanta Bhattacharya, Ph.D., director, Antibody Translational Research Program and principal investigator, Translational Health Science and Technology Institute